Dergiler / Retina-Vitreus / 2021 / Cilt: 30 - Sayı: 2

Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial

Sayfa
204–211
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Laser photocoagulation 1-2 weeks prior to vitrectomy did not lower vitreous concentration of HIF-1α and ICAM-1.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Purpose: The vitreous concentration of Hypoxia-inducible Factor-1α (HIF-1α) and Intercellular Adhesive Molecule-1 (ICAM-1) were related to the permeability of retinal vessels and the grades of macular edema in proliferative diabetic retinopathy (PDR).
📊
Temel Bulgular & Veri:The aim of this study is to determine how pre-treatment with PRP before vitrectomy affect the vitreous level of HIF–1 and ICAM-1 in patients with PDR.
💡
Sonuç & Katkı:Conclusion: Laser photocoagulation 1-2 weeks prior to vitrectomy did not lower vitreous concentration of HIF-1α and ICAM-1.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Purpose: The vitreous concentration of Hypoxia-inducible Factor-1α (HIF-1α) and Intercellular Adhesive Molecule-1 (ICAM-1) were related to the permeability of retinal vessels and the grades of macular edema in proliferative diabetic retinopathy (PDR). Prior studi es have showed that pan-retinal photocoagulation (PRP) is beneficial in treating PDR. The aim of this study is to determine how pre-treatment with PRP before vitrectomy affect the vitreous level of HIF–1 and ICAM-1 in patients with PDR. Materials and Methods: A randomized clinical trial study was conducted to 22 eyes in Cipto Mangunkusumo National General Hospital, Indonesia. At the beginning of PRP, just before vitrectomy, and at 2, 4, and 12 weeks after vitrectomy, central macular thickness (CMT) was measured using optical coherence tomography (OCT). Undiluted vitreous humour was extracted during vitrectomy to obtain HIF-1 α and ICAM-1 concentration. Results: In the control and the photocoagulation group, the average level of HIF-1α (ng/mL) were 0.152±0.015 and 0.164±0.033 respectively. The average level of ICAM-1 (ng/mL) in control group and pre-treated group were 17,840±14,140 and 27,027±10,452 respectively. No statistically significant difference was seen in the level of HIF-1α and ICAM-1 between each group. The correlation between vitreous ICAM- 1 and HbA1c was statistically signi ficant (r=0.463, p=0.03). No signi ficant differences for CMT at pre-vitrectomy, or 2 and 4 weeks after vitrectomy. Statistically significant difference was observed at 12 weeks after follow-up (p=0.049). The correlation between vitreous level of HIF-Iα and CMT in the control and laser group are r = 0.447 and r = 0.32, respectively. Conclusion: Laser photocoagulation 1-2 weeks prior to vitrectomy did not lower vitreous concentration of HIF-1α and ICAM-1.

🔖

Bu Makaleye Atıf Yap

JUSMAN, S. W., VİCTOR, A. A., YANDANDRİ, V. R., GONDOWİARDJO, T. D., DHARMA, R., PRİHARTONO, J. (2022). Effect of Laser Photocoagulation Before Vitrectomy to Hypoxia Inducible Factor-1alfa and Intracellular Adhesive Molecule-1 in Diabetic Patients: A Randomized Clinical Trial. Retina-Vitreus, Cilt: 30 - Sayı: 2, 204–211. https://ajindex.com/articles/589067

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Heng LZ, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, et al. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments - Review Article. Diabet Med. 2013;30:640-50
  2. Tarr J, Kaul K, Chopra M, M Kohner E, Chibber R. Pathophysiology of Diabetic Retinopathy. ISRN Ophthalmol. 2013;2013:1-13
  3. Domingueti CP, Dusse LM, das Graças Carvalho M, de Sousa LP, Gomes KB, Fernandes AP. Diabetes mellitus: the linkage between oxidative stress, in flammation, hypercoagulability and vascular complications. J Diabetes Complications. 2016;30:738-45
  4. Antonetti DA, Klein R, Gardner TW. Mechanism of disease diabetic retinopathy: Review. N Engl J Med. 2012;366:1227-39
  5. Chistiakov DA. Diabetic retinopathy: pathogenic mechanisms and current treatments. Diabetes Metab Syndr. 2011;5:165-72
  6. Girgis CM, Cheng K, Scott CH, Gunton JE. Novel links between HIFs, type 2 diabetes, and metabolic syndrome. Trends Endocrinol Metab. 2012;23(8):372-80
  7. Loukovaara S, Koivunen P, Inglés M, Escobar J, Vento M, Andersson S. Elevated protein carbonyl and HIF-1 α levels in eyes with proliferative diabetic retinopathy. Acta Ophthalmol. 2014;92:323-7
  8. Kurihara T. Roles of hypoxia response in retinal development and pathophysiology. Keio J Med. 2018;67:1-9
  9. Adamiec-Mroczek J, O ficjalska-Młyńczak J, Misiuk-Hoj ło M. Proliferative diabetic retinopathy—The in fluence of diabetes control on the activation of the intraocular molecule system. Diabetes Res Clin Pract. 2009;84:46-50
  10. Funatsu H, Noma H, Mimura T, Eguchi S, Hori S. Association of vitreous in flammatory factors with diabetic macular edema. Ophthalmology. 2009;116:73-9
  11. Abcouwer SF. Angiogenic Factors and Cytokines in Diabetic Retinopathy. J Clin Cell Immunol. 2013; Suppl 1:1-12
  12. Shimura M, Yasuda K, Nakazawa T, Shiono T, Nishida K. Panretinal-photocoagulation before pars plana vitrectomy influences vitreous level of interleukin-6 but not of vascular endothelial growth factor in patients with diabetic retinopathy. Int J Biomed Sci. 2007;3:31-7
  13. ETDRS. Photocoagulation for diabetic macular edema. ETDRS Report Number 1. Arch Opthalmol. 1985;103:1796-806
  14. ETDRS. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology. 1991;98:766-85
  15. Bressler NM, Beck RW, Ferris FL 3rd. Panretinal photocoagulation for proliferative diabetic retinopathy. New Engl J Medicine. 2011;365(16):1520-6
  16. Evans JR, Michelessi M, Virgili G. Laser photocoagulation for